The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 cases and less progress in mortality, even as other experts disagree and cite ...

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

There is currently no screening programme for prostate cancer, the most common cancer in men. But there has been some ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant prostate cancer have many effective treatment options, but questions remain ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Prostate cancer risk factors include some that can’t be changed, such as having a family history of the disease and a genetic predisposition for developing the cancer ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Currently, the UK lacks a national, population-wide screening programme for the disease, despite persistent calls from cancer ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision ...